View in EDS PDF Full Text

First-in-Human Study of [211At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial).

Saved in:
Bibliographic Details
Title: First-in-Human Study of [211At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial).
Authors: Watabe T; Department of Radiology, Graduate School of Medicine, University of Osaka, Osaka, Japan; watabe.tadashi.med@osaka-u.ac.jp.; Institute for Radiation Sciences, University of Osaka, Osaka, Japan., Mukai K; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Naka S; Department of Pharmacy, University of Osaka Hospital, Osaka, Japan., Sasaki H; Department of Medical Technology, University of Osaka Hospital, Osaka, Japan., Kamiya T; Department of Medical Technology, University of Osaka Hospital, Osaka, Japan., Hayakawa T; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Fukuhara A; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Takano T; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Shirakami Y; Institute for Radiation Sciences, University of Osaka, Osaka, Japan., Ooe K; Institute for Radiation Sciences, University of Osaka, Osaka, Japan., Shigeno S; Department of Gastroenterology and Hepatology, Graduate School of Medicine, University of Osaka, Osaka, Japan.; Medical Innovation Center, University of Osaka Hospital, Osaka, Japan., Okamura S; Medical Innovation Center, University of Osaka Hospital, Osaka, Japan., Masumura K; Medical Innovation Center, University of Osaka Hospital, Osaka, Japan., Hida E; Department of Biostatistics and Data Science, Graduate School of Medicine, University of Osaka, Osaka, Japan; and., Haba H; RIKEN Nishina Center for Accelerator-Based Science, Wako, Japan., Toyoshima A; Institute for Radiation Sciences, University of Osaka, Osaka, Japan., Isohashi K; Department of Radiology, Graduate School of Medicine, University of Osaka, Osaka, Japan., Shimomura I; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan., Tomiyama N; Department of Radiology, Graduate School of Medicine, University of Osaka, Osaka, Japan.; Institute for Radiation Sciences, University of Osaka, Osaka, Japan.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Dec 03; Vol. 66 (12), pp. 1941-1947. Date of Electronic Publication: 2025 Dec 03.
Publication Type: Journal Article; Clinical Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40998730
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: First-in-Human Study of [<superscript>211</superscript>At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Watabe+T%22">Watabe T</searchLink>; Department of Radiology, Graduate School of Medicine, University of Osaka, Osaka, Japan; watabe.tadashi.med@osaka-u.ac.jp.; Institute for Radiation Sciences, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Mukai+K%22">Mukai K</searchLink>; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Naka+S%22">Naka S</searchLink>; Department of Pharmacy, University of Osaka Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Sasaki+H%22">Sasaki H</searchLink>; Department of Medical Technology, University of Osaka Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kamiya+T%22">Kamiya T</searchLink>; Department of Medical Technology, University of Osaka Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hayakawa+T%22">Hayakawa T</searchLink>; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuhara+A%22">Fukuhara A</searchLink>; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Takano+T%22">Takano T</searchLink>; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Shirakami+Y%22">Shirakami Y</searchLink>; Institute for Radiation Sciences, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ooe+K%22">Ooe K</searchLink>; Institute for Radiation Sciences, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Shigeno+S%22">Shigeno S</searchLink>; Department of Gastroenterology and Hepatology, Graduate School of Medicine, University of Osaka, Osaka, Japan.; Medical Innovation Center, University of Osaka Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Okamura+S%22">Okamura S</searchLink>; Medical Innovation Center, University of Osaka Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Masumura+K%22">Masumura K</searchLink>; Medical Innovation Center, University of Osaka Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hida+E%22">Hida E</searchLink>; Department of Biostatistics and Data Science, Graduate School of Medicine, University of Osaka, Osaka, Japan; and.<br /><searchLink fieldCode="AU" term="%22Haba+H%22">Haba H</searchLink>; RIKEN Nishina Center for Accelerator-Based Science, Wako, Japan.<br /><searchLink fieldCode="AU" term="%22Toyoshima+A%22">Toyoshima A</searchLink>; Institute for Radiation Sciences, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Isohashi+K%22">Isohashi K</searchLink>; Department of Radiology, Graduate School of Medicine, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Shimomura+I%22">Shimomura I</searchLink>; Department of Metabolic Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tomiyama+N%22">Tomiyama N</searchLink>; Department of Radiology, Graduate School of Medicine, University of Osaka, Osaka, Japan.; Institute for Radiation Sciences, University of Osaka, Osaka, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2025 Dec 03; Vol. 66 (12), pp. 1941-1947. <i>Date of Electronic Publication: </i>2025 Dec 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40998730
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.125.270810
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1941
    Titles:
      – TitleFull: First-in-Human Study of [211At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Watabe T
      – PersonEntity:
          Name:
            NameFull: Mukai K
      – PersonEntity:
          Name:
            NameFull: Naka S
      – PersonEntity:
          Name:
            NameFull: Sasaki H
      – PersonEntity:
          Name:
            NameFull: Kamiya T
      – PersonEntity:
          Name:
            NameFull: Hayakawa T
      – PersonEntity:
          Name:
            NameFull: Fukuhara A
      – PersonEntity:
          Name:
            NameFull: Takano T
      – PersonEntity:
          Name:
            NameFull: Shirakami Y
      – PersonEntity:
          Name:
            NameFull: Ooe K
      – PersonEntity:
          Name:
            NameFull: Shigeno S
      – PersonEntity:
          Name:
            NameFull: Okamura S
      – PersonEntity:
          Name:
            NameFull: Masumura K
      – PersonEntity:
          Name:
            NameFull: Hida E
      – PersonEntity:
          Name:
            NameFull: Haba H
      – PersonEntity:
          Name:
            NameFull: Toyoshima A
      – PersonEntity:
          Name:
            NameFull: Isohashi K
      – PersonEntity:
          Name:
            NameFull: Shimomura I
      – PersonEntity:
          Name:
            NameFull: Tomiyama N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 12
              Text: 2025 Dec 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1535-5667
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
              Type: main
ResultId 1